Skip to content

Development of an AI Platform for the Analysis of Sperm and Prediction of Their Clinical Potential

Development and Validation of an Artificial Intelligence Platform for the Analysis of Sperm Samples and Prediction of Their Clinical Potential

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07456397
Acronym
Spermy01
Enrollment
500
Registered
2026-03-06
Start date
2026-03-18
Completion date
2028-02-01
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICSI, Infertility (IVF Patients), IVF Outcomes, Male Infertility, Reproductive Issues

Brief summary

Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to develop an artificial intelligence platform for the analysis of sperm samples and prediction of their clinical potential, in 500 semen samples, in an in vitro study over 24 months.

Interventions

DEVICESwim-up

Sperm samples will be processed by swim-up technique

Sperm samples will be processed by density gradient centrifugation

Sperm samples will be processed by HyperSperm

Sponsors

Fecundis Lab SL
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Male participants: Inclusion Criteria: * Ability to provide a semen sample via masturbation * Semen sample intended for use in an IVF/ICSI cycle

Exclusion criteria

* Current diagnosis of a sexually transmitted infection (STI) * Previous diagnosis of hepatitis A, B, C, D, or HIV * Prior participation in this study * Participation in a clinical trial involving an intervention within the last 3 months Female participants: Inclusion Criteria: * Urdengoing an IVF/ICSI cycle with partner or donor semen

Design outcomes

Primary

MeasureTime frameDescription
Predictive performance of AI models for reproductive outcomesUp to confirmation of clinical pregnancy: approximately 6-8 weeks after embryo transfer.Area Under the Receiver Operating Characteristic Curve (AUC) and R² (for continuous outcomes) evaluating the ability of the AI model to predict fertilization rate, blastocyst development rate, and pregnancy outcomes using pseudonymized clinical and semen analysis data.

Countries

Spain

Contacts

CONTACTMatias D. Gomez Elias, PhD
mgomezelias@fecundis.com+34624174355
PRINCIPAL_INVESTIGATORMariona Rius Mas, PhD

Fertty

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026